Jun 12, 2026 08:10AM
Jun 4, 2026 05:22AM
May 5, 2026 07:30AM
Apr 28, 2026 06:24AM
Apr 27, 2026 02:52PM
Apr 27, 2026 11:50AM
Apr 27, 2026 10:20AM Leerink on Compass Therapeutics (CMPX): 'there are multiple sources of long-term upside'
Apr 27, 2026 08:27AM
Apr 27, 2026 08:15AM
Apr 27, 2026 08:08AM
Apr 27, 2026 07:30AM
Apr 27, 2026 07:30AM
Mar 5, 2026 07:30AM
Jan 14, 2026 10:39AM The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
Jan 5, 2026 04:31AM
Dec 22, 2025 07:06AM
Dec 3, 2025 03:16AM
May 8, 2025 08:00AM
Apr 1, 2025 07:01AM
Apr 1, 2025 07:00AM
Nov 12, 2024 08:00AM Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Sep 16, 2024 06:49AM
Aug 12, 2024 08:00AM
May 13, 2024 08:00AM
Apr 25, 2024 08:00AM
Apr 16, 2024 08:00AM
Mar 21, 2024 09:00AM
Feb 28, 2024 08:00AM Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial
Jan 5, 2024 08:03AM
Jan 5, 2024 08:00AM
Nov 9, 2023 07:30AM
Jun 22, 2023 04:07PM
Nov 9, 2022 04:10PM
Nov 9, 2022 09:00AM
Jul 18, 2022 07:05AM Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position
May 16, 2022 08:00AM
May 9, 2022 08:00AM
Mar 21, 2022 08:02AM
Mar 21, 2022 08:00AM
Jan 20, 2022 08:37AM
Jan 20, 2022 08:30AM
Nov 12, 2021 08:30AM Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 1, 2021 04:03PM

323,150 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All